A tRNA modification in Mycobacterium tuberculosis facilitates optimal intracellular growth
eLife · 27.09.2023 · 12
DOI: 10.7554/elife.87146 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 27.09.2023. Verfasst von Francesca G Tomasi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Infectious Diseases Harvard T. H. Chan School of Public Health, Boston, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Howard Hughes Medical Institute, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Diverse chemical modifications fine-tune the function and metabolism of tRNA. Although tRNA modification is universal in all kingdoms of life, profiles of modifications, their functions, and physiological roles have not been elucidated in most organisms including the human pathogen, Mycobacterium tuberculosis ( Mtb ), the causative agent of tuberculosis. To identify physiologically important modifications, we surveyed the tRNA of Mtb , using tRNA sequencing (tRNA-seq) and genome-mining. Homology searches identified 23 candidate tRNA modifying enzymes that are predicted to create 16 tRNA modifications across all tRNA species. Reverse transcription-derived error signatures in tRNA-seq predicted the sites and presence of nine modifications. Several chemical treatments prior to tRNA-seq expanded the number of predictable modifications. Deletion of Mtb genes encoding two modifying enzymes, TruB and MnmA, eliminated their respective tRNA modifications, validating the presence of modified sites in tRNA species. Furthermore, the absence of mnmA attenuated Mtb growth in macrophages, suggesting that MnmA-dependent tRNA uridine sulfation contributes to Mtb intracellular growth. Our results lay the foundation for unveiling the roles of tRNA modifications in Mtb pathogenesis and developing new therapeutics against tuberculosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Infectious Diseases Harvard T. H. Chan School of Public Health, Boston, United States.
- Division of Infectious Diseases, Brigham and Women's Hospital, Boston, United States.
- Department of Microbiology, Harvard Medical School, Boston, United States.
- Howard Hughes Medical Institute, Boston, United States.
ORCID-Profile: Satoshi Kimura, Eric J Rubin, Matthew K Waldor
Förderung
- NIAID NIH HHS
- Howard Hughes Medical Institute
- National Institute of Allergy and Infectious Diseases
- Harvard Medical School
Zitieren
APA
Tomasi, F. G., Kimura, S., Rubin, E. J., & Waldor, M. K. (2023). A tRNA modification in Mycobacterium tuberculosis facilitates optimal intracellular growth. eLife, 12. https://doi.org/10.7554/elife.87146
Vancouver
Tomasi FG, Kimura S, Rubin EJ, Waldor MK. A tRNA modification in Mycobacterium tuberculosis facilitates optimal intracellular growth. eLife. 2023;12. doi:10.7554/elife.87146
BibTeX
@article{Tomasi2023,
author = {Tomasi, Francesca G and Kimura, Satoshi and Rubin, Eric J and Waldor, Matthew K},
title = {A tRNA modification in Mycobacterium tuberculosis facilitates optimal intracellular growth},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.87146}
}
EUVIMED